Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246636
Status:
COMPLETED
Last Update Posted:
2009-12-14
First Post:
2005-10-28
Brief Title:
Evaluation of Efficacy and Safety of Omacor Omega-3-acid Ethyl Esters as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara Fenofibrate Followed by an 8-week Extension
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
OM5 program Reliant
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Study Director
Old Organization:
GSK